Sign in to confirm you’re not a bot
This helps protect our community. Learn more

When a Drug Becomes a Child’s Last Hope for T-Cell Leukemia | Albert Einstein College of Medicine

Albert Einstein College of Medicine
76.4K subscribers
17K views 6 years ago #research #drugdevelopment #EnzymeInhibitors
Albert Einstein College of Medicine scientist Vern Schramm never imagined that his lifelong quest to decode enzyme inhibitors would intersect with the life of two-year-old Katie, who had an incurable form of T-cell acute lymphoblastic leukemia (T-cell ALL). Dr. Schramm, Katie Lambertson, now a teenager, and her parents Jeff and Linda, share their stories about the road to drug development and the experimental drug treatment that would change the course of their lives. #tcellleukemia #research #drugdevelopment #EnzymeInhibitors ...more
...more
When a Drug Becomes a Child’s Last Hope for T-Cell Leukemia | Albert Einstein College of Medicine
156Likes
17,955Views
2018Nov 5
Albert Einstein College of Medicine scientist Vern Schramm never imagined that his lifelong quest to decode enzyme inhibitors would intersect with the life of two-year-old Katie, who had an incurable form of T-cell acute lymphoblastic leukemia (T-cell ALL). Dr. Schramm, Katie Lambertson, now a teenager, and her parents Jeff and Linda, share their stories about the road to drug development and the experimental drug treatment that would change the course of their lives. #tcellleukemia #research #drugdevelopment #EnzymeInhibitors

Follow along using the transcript.

Albert Einstein College of Medicine

76.4K subscribers